Late 2022/early 2023 in china if phase 3 is started before the year is out I would say, a year longer for the US. This stuff should become more available on the grey market next year, so some group buys could happen if the phase 2 results are positive enough :)
The main hype surrounding Kintor atm is from pyrilutamide (KX-826), their topical that just finished phase 2 trials in China and should be going into phase 3 by the end of this year. It should provide an equally effective treatment to Fina/Duta minus the side effects if it works properly. i...
https://investors.histogen.com/news-releases/news-release-details/histogen-provides-update-its-development-programs-and-pipeline
They've suspended HST-001 and are reallocating resources. Looks like that's it.